Patient pathways for rare liver diseases: a European template developed by ERN RARE-LIVER.

IF 3.6 2区 医学 Q2 GENETICS & HEREDITY
Sarah Raevens, Renée Duijzer, Andreea Fodor, Matt Bolz Johnson, Nagham Issa, Sophie Pénisson, Samir Patel, Alice Bertolini, Carmen A J Teemer, Clemence Ramier, Laure Elkrief, Marco Senzolo, Virginia Hernandez-Gea, Ansgar W Lohse, Bogdan Procopet, Joost P H Drenth, Aurélie Plessier
{"title":"Patient pathways for rare liver diseases: a European template developed by ERN RARE-LIVER.","authors":"Sarah Raevens, Renée Duijzer, Andreea Fodor, Matt Bolz Johnson, Nagham Issa, Sophie Pénisson, Samir Patel, Alice Bertolini, Carmen A J Teemer, Clemence Ramier, Laure Elkrief, Marco Senzolo, Virginia Hernandez-Gea, Ansgar W Lohse, Bogdan Procopet, Joost P H Drenth, Aurélie Plessier","doi":"10.1186/s13023-026-04556-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Rare liver diseases are associated with diagnostic delay, fragmented care, inconsistent management, and limited patient support. Patient pathways may help address these challenges by translating clinical guidance and patient priorities into practical, coordinated care processes.</p><p><strong>Main body: </strong>This manuscript presents a European template for developing patient-centred pathways for rare liver diseases within ERN RARE-LIVER. The template was developed through multidisciplinary collaboration involving hepatologists, specialist nurses, patient representatives, patient organisations, and EURORDIS, and was informed by clinical guidance, patient-journey principles, and iterative expert and patient review. The proposed framework follows four phases of the patient journey: pre-diagnosis, diagnosis, management, and long-term follow-up. It includes disease-specific sections, educational resources, frequently asked questions, and \"10 key questions\" to support shared decision-making. Pathways for non-cirrhotic portal vein thrombosis, polycystic liver disease, and portosinusoidal vascular disorder illustrate the practical application of the template.</p><p><strong>Conclusion: </strong>This European template provides a practical, adaptable framework aimed at supporting harmonised, multidisciplinary, and patient-centred care for rare liver diseases across European healthcare settings. Future work should evaluate implementation, usability, and impact on care coordination and patient experience.</p>","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":"21 1","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2026-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13570500/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orphanet Journal of Rare Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13023-026-04556-3","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Rare liver diseases are associated with diagnostic delay, fragmented care, inconsistent management, and limited patient support. Patient pathways may help address these challenges by translating clinical guidance and patient priorities into practical, coordinated care processes.

Main body: This manuscript presents a European template for developing patient-centred pathways for rare liver diseases within ERN RARE-LIVER. The template was developed through multidisciplinary collaboration involving hepatologists, specialist nurses, patient representatives, patient organisations, and EURORDIS, and was informed by clinical guidance, patient-journey principles, and iterative expert and patient review. The proposed framework follows four phases of the patient journey: pre-diagnosis, diagnosis, management, and long-term follow-up. It includes disease-specific sections, educational resources, frequently asked questions, and "10 key questions" to support shared decision-making. Pathways for non-cirrhotic portal vein thrombosis, polycystic liver disease, and portosinusoidal vascular disorder illustrate the practical application of the template.

Conclusion: This European template provides a practical, adaptable framework aimed at supporting harmonised, multidisciplinary, and patient-centred care for rare liver diseases across European healthcare settings. Future work should evaluate implementation, usability, and impact on care coordination and patient experience.

罕见肝病的患者路径:由ERN rare - liver开发的欧洲模板。
背景:罕见肝病与诊断延迟、护理分散、管理不一致和患者支持有限有关。患者路径可以通过将临床指导和患者优先事项转化为实际、协调的护理过程来帮助解决这些挑战。正文:这份手稿提出了一个欧洲模板,用于发展以患者为中心的途径,治疗罕见肝病。该模板是通过多学科合作开发的,包括肝病学家、专科护士、患者代表、患者组织和EURORDIS,并根据临床指导、患者旅程原则和反复的专家和患者审查提供信息。建议的框架遵循患者旅程的四个阶段:预诊断、诊断、管理和长期随访。它包括特定疾病部分、教育资源、常见问题和“10个关键问题”,以支持共同决策。非肝硬化门静脉血栓形成、多囊性肝病和门窦血管紊乱的途径说明了该模板的实际应用。结论:这个欧洲模板提供了一个实用的、适应性强的框架,旨在支持整个欧洲医疗保健环境中罕见肝病的协调、多学科和以患者为中心的护理。未来的工作应评估实施、可用性以及对护理协调和患者体验的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases 医学-医学:研究与实验
CiteScore
6.30
自引率
8.10%
发文量
418
审稿时长
4-8 weeks
期刊介绍: Orphanet Journal of Rare Diseases is an open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs. The journal does not accept case reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书